Macro Dragon: US back in, China Coronavirus, BoJ, US/EU Tech Tues? Macro Dragon: US back in, China Coronavirus, BoJ, US/EU Tech Tues? Macro Dragon: US back in, China Coronavirus, BoJ, US/EU Tech Tues?

Macro Dragon: US back in, China Coronavirus, BoJ, US/EU Tech Tues?

Macro 2 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Macro Dragon = Daily Cross-Asset Global Views

Today we glance over BoJ wash & potential US/EU Tech Tues. We also check in on the SARs like coronavirus that is hitting China as the Lunar New Year Migration (+3bn trips) is in the works with next wk being Chinese New Years. This has already had an equity price impact on leisure, travel as well as drug making China stocks overnight. Will be interesting to see if we get any US leadership for the bulls, as they get back in post MLK Mon.

(Note that these are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations.)



Macro Dragon: China Coronavirus, BoJ, US/EU Tech Tues, US Back in


Today see’s the US back in…

So US back in today after MLK mon, which may bring some more leadership for the equity bulls – Europe was down across the board yest, with the key divergence to the upside being the DAX +0.17% 13548.

Remember the key near-term market risk highlighted yest that could reverse the DAX & further damped European equities. If we get a US/EU fallout (Trump vs. Macron), then we could have a brand new trade war. And yes, it would be classic Trump scrapbook playbook (if there is such a thing) – put out the window dressing exercise fire with China (for now), then immediately start a new one up with the EU (threaten their dax autos)


…While we have the coronavirus heading into Chinese New Year…

If a virus could pick an opportune time to hit the China, then there really is no better time for potential spreading than during the Chinese lunar new year, which marks the biggest annual human migration in the world. According to Bloomberg up to 3bn trips (railways, airlines, cars, boats, etc) will be done over this period. The new coronavirus is similar to the SARS virus which killed 800 people 17hrs back – whilst that is not large on the greater scale of the population of HK (where it broke out), it caused massive hysteria & panic during a small period, where people were literally giving away their homes for peanuts.

Whilst the situation is dynamic & fluid - So far its reported that over 200 people are ill, with Wuhan (city of 11m) looking like location-zero. So far there have only been 3 confirmed fatalities linked to the virus, which – early days – potentially suggests a lower mortality rate than say MERs which kills up to 1/3 of those it infects. SARS on the other hand, had a fatality rate closer to 10%.  

There have also been at least 4 confirmed cases of people who have left China (2 in Thailand, 1 in Japan & at least one in South Korea) that are infected with the corona virus. That number itself, suggests that statistically there should be a lot more ill people on the ground.

China has stepped up its speed in disclosure & transparency compared to previous outbreaks which is a huge positive for everyone. Obviously potential outbreaks are a fine line for any government – your priority is to contain, as well as educate the public, yet the last thing you want to do is induce a panic (i.e. some of the misinformation & lack of education in Ebola cases in Africa were just downright diabolical).

There is no doubt that eventually the virus will be contained – its just a question of when & does it scale in magnitude. Hard to see a case where this becomes super negative for CH (& proxy HK) equities, unless it somehow induces local panic selling – yet things would have to get dramatically worse for such a scenario. It would then be retail, travel & leisure stocks being hit, whilst biotech, healthcare plus defensive names would get bid. Still we got a taste of that overnight, with some CH drug makers having limit up days while Macau names & airlines had a tough session – obviously when the virus gets nipped in the bud, these moves should potentially mean-revert.  

The WHO is conducting an emergency meeting not immediately on Wed Jan 23 in Geneva, which could determine whether this gets raised to international status concern. Which to KVP is the paragon of incompetence & disconnected elitism in regard to procedures: any outbreak, anywhere in the world where the virus is jumping from human to human is of international concern.

One great thing about Asia – for those who have not traveled – is most airports have standard checkups for flus & sickness through temperature cams & officials monitoring travelers from potential high risk destinations. Talk about a role with a negative skew, if your successful in your job there is a chance you may catch something (like being a water digger - assuming you get paid per hour).  

End of the day, this is one to keep watching. And its worth noting that they have cured over 25 people who have caught the virus so far.

The BoJ later today…

  • The BoJ should be a wash, hard for KVP seeing any stimulus with DollarYen well north of 100 & it is almost inconceivable to see a move higher in rates given the outright level of debt in the system

Have a great wk everyone, good luck out there & don’t forget to keep your mind open to opportunities. For those travelling over Chinese New Year’s; Godspeed, smooth travels & have a well deserved break with loved ones. The year of the metal rat is going to be phenomenal!




On The Radar Today: (Times would be SGT)

  • NZ: Milk auction
  • JP: BoJ Rate Decision Meeting
  • UK: Jobs data   
  • EZ: ZEW economic sentiment  
  • CA: Mfg. Sales


Some Anchor Pieces from #SaxoStrats:


Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.